Rationale, Visionen und Grenzen der Immunonkologie: Checkpoint-Inhibition als neue Therapiesäule der Tumortherapie

Publisher： Karger

E-ISSN： 2296-5262|38|3|2-5

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.3, 2015-04, pp. : 2-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunonkologie «Coming of Age» - die nächste Generation der Immun-Checkpoint-Inhibitoren

By  

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-09 ,pp. : 6-9

Karger

Access to resources Recommend Favorite

4.1.2 Neue pharmakologische Prinzipien der Tumortherapie

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 53-57

Karger

Access to resources Recommend Favorite

Molekulare Bildgebung in der Tumortherapie

By Weber W.A.  

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 53, Iss. 8, 2010-08 ,pp. : 810-817

Springer Publishing Company

Access to resources Recommend Favorite

2.1.2 Langzeitfolgen der Tumortherapie

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 13-14

Karger

Access to resources Recommend Favorite

Organerhaltung, multimodale radikale Tumortherapie und Reduktion der therapiebedingten Morbidität

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 46, Iss. 1-2, 2006-01 ,pp. : 1-2

Karger

Access to resources Recommend Favorite